MKI67 and breast carcinoma: In this study, by inviting 21 pathologists to assess Ki67 scores of the same set of luminal-like breast cancer specimens, we were able to evaluate the practicability of three guidelines (IKWG, NHCC, and NHCCa9), as well as that of Quantitative Dot Blot (QDB)-based Ki67, in daily clinical practice.